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Abstract—A composite model, describing the glucose/insulin
dynamics following daily food administration and insulin in-
jections in Type 1 Diabetes Mellitus patients is presented.
Three daily meals have been simulated, food intake representing
four different types of foodstuffs, along with three rapid-acting
insulin injections and one long-acting insulin injection. Three
different scenarios (depending on whether food intake and/or
administration times were fixed or random) were hypothesized:
simulations show a very realistic time-course for both glucose
and insulin dynamics over long (20 days) and short (one day)
time periods.
I. INTRODUCTION
Type 1 Diabetes Mellitus (T1DM) is a form of diabetes that
mainly results from the autoimmune destruction of β-cells, the
pancreatic cells that produce, store and release insulin [1]. In
healthy individuals, insulin secretion from pancreatic β-cells
is stimulated in response to meals and is reduced to a low
basal rate during the post-absorptive state. The main role of
insulin is to regulate carbohydrate and fat metabolism in the
body, promoting glucose uptake from tissues so that plasma
glucose levels are maintained within a narrow range.
In T1DM, hyperglycemia (in the absence of naturally oc-
curring insulin) can be controlled with exogenous insulin,
commonly administered by subcutaneous injections at periodic
intervals several times per day, mostly in correspondence of
meals (though other options exist, such as insulin pumps).
In order to best mimic insulin release in healthy subjects,
insulin regimens often foresee the use of short-acting (e.g.
regular human insulin) or rapid-acting (e.g. insulin lispro [2] or
insulin aspart) insulin, administered within 15 minutes before
a meal or immediately after a meal, along with the use of
intermediate- or long-acting [3] insulin [4]. This approach
is often referred as multiple daily injection (MDI) insulin
therapy. The pre-meal short- or rapid-acting insulin addresses
insulin requirements associated with the carbohydrate content
of meals, while the longer-acting insulin addresses basal
insulin requirements, i.e. the amount of insulin required to
maintain glycaemic control between meals and during the
overnight period. With this kind of therapeutic plan three to
five injections per day are required. Alternative therapeutic
schemes foresee twice-daily injection of mixtures of short-
and longer-acting insulins (either self-prepared or ready-made,
according to fixed ratio mixtures).
In any case, the objective is the optimal control in order
to reduce hyperglycaemia, which is associated with long-
term microvascular damage, blindness, renal impairment and
peripheral neuropathy [5]. Another necessary objective is
to reduce the risk of hypoglycemia, which represents the
most common adverse effect associated with insulin-based
therapies: severe hypoglycemia is extremely unpleasant, can
determine seizures and may even cause death.
The aim of the present work is that of simulating, by a
modeling approach, both real-life insulin therapy schemes and
real-life (composite) meals, determining the resulting daily
plasma glucose profiles. The model presented combines two
sub-models: a recently developed simple mathematical model
for the interpretation of data from an Oral Glucose Tolerance
Test (OGTT) [6] and a complementary model representing
rapid- and long-acting insulin injections. Therefore, while
the original OGTT/meal model included a representation of
spontaneous insulin secretion, in the present work the equa-
tions expressing the pancreatic response to glucose stimuli are
replaced by equations describing exogenous insulin kinetics.
Simulations were run for a time sufficient to reach regime
profiles under all simulated scenarios. Results related to the
last day from each scenario are presented and compared.
II. MODELS AND METHODS
A. The composite Glucose-Insulin Model
A block diagram of the whole model is shown in Fig. 1.
It consists of two sub-models. The first sub-model describes
glucose dynamics in 5 main compartments, corresponding to
four differential equations, a set of ”stomach” compartments
(each of them representing a different foodstuff type), and one
algebraic equation. The second sub-model describes insulin
kinetics: it is composed of three differential equations corre-
sponding to the fast and slow insulin depot compartments and
to the (unique) plasma insulin compartment.
1) The Glucose dynamics sub-model: The glucose sub-
model is a modified version of an already published model
[6]. It differs by the introduction of different ”stomach” com-
partments in parallel, in order to take into account the hetero-
geneous foodstuff composition of real meals. Each ”stomach”
compartment is therefore categorized by a different glycemic
index, that is by the speed at which the glucose content in the
food passes to jejunum and is then made available. In order to
simplify the physiological analysis, the caloric contribution of
non-carbohydrate foodstuffs has been represented in terms of
the quantity of glucose which they eventually spare. In this
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sense, while it is actually possible for some protein to be
converted to glucose itself (gluconeogenesis), fats essentially
compete with glucose for entry into the Krebs (citric acid)
cycle, thus determining a glucose sparing effect which is
responsible, at least in part, for the insulin resistance deriving
from high-fat diets (Randles cycle).
The equations of the sub-model are as follows:
dSi(t)
dt
= −kjsSi(t), Si(0) = piDj ,






kjsiSi(t)− kgjJ(t)− krjJ(t), J(0) = 0 (2)
dR(t)
dt
= krjJ(t)− klrR(t), R(0) = 0 (3)
dL(t)
dt
= klrR(t)− kglL(t), L(0) = 0 (4)
dG(t)
dt





, G(0) = Gb (5)
where
GPROD(t) = T1ge
−λ1gG(t) + T2gie−λ2gG(t)I(t) (6)
and from the steady state conditions





Details about the above sub-model are reported in [6].
Briefly, G represents plasma glucose concentrations, Si, J
and L are glucose-equivalent amounts in several ”stomach”
compartments, in the jejunum and ileum, following a meal
intake whose foodstuffs are indexed by i and are in proportion
of pi. The R compartment is a delay compartment necessary to
describe the transit of the glucose load through the intestinal
lumen. Stomach glucose dynamics is described by (1). The
elimination (emptying) terms depend on glucose-equivalent
amounts, where kjsi is the glucose transfer rate from ”stom-
ach” i to the jejunum. From the jejunum glucose passes to the
ileum through a delay compartment R, and is absorbed with
two potentially different transfer rate constants (kgj and kgl).
Equation (5) describes glucose dynamics, with the first
term on the right-hand side representing spontaneous glucose
elimination rate and with the second term representing glucose
tissue uptake due to insulin effect. kxgi, the insulin-dependent
glucose elimination rate, represents an index of insulin sen-
sitivity. The Hepatic Glucose Output (HGO) described in (6)
is dependent on circulating plasma glucose and insulin. Liver
TABLE I
MODEL PARAMETER DESCRIPTION AND VALUES
Parameter Description Value
GLUCOSE-SUB-MODEL
Gb [mM ] basal plasma glucose 6.9
concentration immediately
before glucose administration
Dj [mmol] dose of glucose 417
administered at meal j 1389
972
pi [#] proportion of foodstaff type i table III
Vg [Lkg−1] apparent glucose distribution volume 0.19
BW [kg] weight 65
kjsi [min
−1] glucose transfer rate from 0.1, 0.05
stomach i to jejunum 0.025,0.01
kgj [min−1] glucose transfer rate from jejunum 0.042
to plasma
krj [min−1] glucose transfer rate from jejunum 0.09
to delay compartment
klr [min−1] glucose transfer rate from the delay 0.06
compartment to ileum
kgl [min−1] glucose transfer rate from 0.27
ileum to plasma
kxg [min−1] insulin independent first order 0.001
glucose elimination rate
kxgi [min−1pM−1] insulin dependent second order 5× 10−5
glucose elimination rate
T1g [min−1mM ] maximal rate of liver glucose determined
production (in plasma concentration
units) as dependent only
on glycemia
T2gi [min−1mM ] maximal rate of liver glucose 0
(in plasma concentration units)
production as dependent on both
glycemia and insulinemia
λ1g [mM−1] rate of decay of liver glucose 0.58
production with increasing glycemia
λ2gi [mM−1pM−1] rate of decay of liver glucose 0
production with increasing
glycemia and insulinemia
f [#] fraction of bioavailable glucose from 0.80
gastrointestinal tract
INSULIN-SUB-MODEL
DkS [pmol] quantity of injected slow insulin table 11
DjF [pmol] quantity of injected fast insulin table 11
Vi [Lkg−1] apparent insulin distribution volume 0.72
Ib [pM ] basal plasma insulin concentration 130
immediately before glucose
administration
ksi [min−1] first order slow insulin 0.0006
elimination rate
kfi [min−1] first order fast insulin 0.0115
elimination rate
kxi [min−1] first order insulin 0.02
elimination rate
b [#] bioavailability of fast insulin 0.65
glucose production is suppressed and glycogen-synthesis is
enhanced in the presence of high plasma glucose and insulin
concentrations. The first term in (6) describes net HGO as
only dependent on plasma glucose levels, while the second
term captures the response of the liver in the presence of high



































Fig. 1. Block diagram of the model. Schematic representation of the two
sub-models. Mji represents the administered foodstuff i at time j and Si the
respective glucose quantity in the Stomach. J , R and L is for the glucose
content in the jejunum, in a delay compartment and in the ileum. G indicates
the glucose concentration in plasma. The Insulin sub-model is composed of
three compartments: the slow-acting insulin depot IS , the fast-acting insulin
depot IF , while DkS and DjF the respective insulin doses. Compartment
I is the plasma insulin concentration and Vi the corresponding apparent
distribution volume. Continuous lines represent entry or exit fluxes while
dotted ones stimulation (arrows) or inhibition (black circles) mechanisms.
appearance into plasma due to meals, which goes through
the ”stomach” compartments and is absorbed from the small
bowel. Since not all of the administered glucose amount is
effectively absorbed, this term is multiplied by a fraction of
absorption f . Table I reports description of model parameters
as well as the values used in the simulations.
2) The Insulin dynamic sub-model: It describes the kinetics






δ(t− tk)DkS , IS(0) = 0 (9)
dIF (t)
dt
= −kfiIF (t) +
∑
j




kfiIF (t) + ksiIS(t)
ViBW
− kxiI(t), I(0) = Ib (11)
where IS and IF represent the amounts of slow-acting and
fast-acting insulin in the subcutaneous depot. Injection dose
DjF of fast insulin occurs at time tj , in correspondence of
daily meal j for j = 1, 2, 3. The slow dose insulin DkS is
administered once daily before bed rest at time tk. I is the
serum insulin concentration, whereas ksi and kfi are the rate
transfer constants from the slow and fast subcutaneous depots
to the serum compartment. Parameter kxp is the elimination
rate from plasma, Vi is the apparent distribution volume, b is
the bio-availability of fast acting insulin (0.65 in this case),
and δ is the Dirac delta, by means of which the succession of
insulin injections is represented in the differential equations.
B. Simulation approach
All simulations are based on the real therapeutic schedule
adhered to a 51 year-old female patient with T1DM. The
therapy is reported in Table II; it is based on the use of a
type of rapid-acting insulin (insulin lispro) administered at the
time of each meal, along with the use of a long-acting insulin
(insulin glargine), administered around 10:00 PM.
Table III reports the meal compositions. We have hypothe-
sized a ”basal” daily caloric intake of 2000 Kcal, divided into
3 meals per day (300 Kcal mean caloric intake breakfast, 1000
Kcal lunch, 700 Kcal dinner). As 1 gr of glucose corresponds
to 3.74 Kcal, the amount of administered glucose-equivalent
is about equal to 75 gr at breakfast, 250 gr at lunch and 175
gr at dinner. Each meal is hypothesized to be composed of
four different foodstuffs: simple sugars (foodstuff type A, e.g.
orange juice), complex carbohydrates (type B, e.g. bread or
potatoes), protein (type C, e.g. a lean steak) and fatty foods
(type D, e.g. olive oil). Percentage composition of each meal,
in terms of foodstuff types is reported in Table III.
TABLE II
THERAPEUTIC SCHEDULING
Breakfast Lunch Dinner Before sleeping
Fasting insulin UI 4 12 12
pmol (28000) (84000) (84000)
Slow Insulin UI 22
pmol (154000)
TABLE III
COMPOSITION OF THE DAILY FOOD INTAKE
Breakfast Lunch Dinner
A: simple sugar 10% 0% 0%
(i.e.orange juice)
B: complex carbohydrate 60% 40% 10%
(i.e.pasta, potatoes)
C: protein 20% 40% 50%
(i.e.steak)
D: fatty food 10% 20% 40%
(i.e.fries, cheese)
Three simulation scenarios have been considered each run-
ning for 20 days in order to achieve a stable regime. In the first
scenario (”basal” scenario) each meal occurs at exactly the
same time and in exactly the same quantity over all simulated
days: breakfast is always given at 8:00 AM, lunch at 1:00
PM and dinner at 8:00 PM. The sum of the gramms of
administered glucose corresponds to the ”basal” caloric intake.
In the second scenario, while the proportional meal compo-
sition (among the several types of foodstuff) and the admin-
istration times remains constant and unchanged, the adminis-
tered glucose content at each meal is a random realization from
a truncated normal distribution centered on the mean quantity
of glucose (administered in the ”basal” scenario) and with a
standard deviation of 20% of the mean value. Low and high
limits of the distribution were set to ±60% of the mean value.
In the third scenario, besides having random quantities,
randomness also occurs in the times at which meals are
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administered, while proportional meal composition remains
constant (reflecting the gastronomic choices of the subject:
always cappuccino, pastry and jam at breakfast, a big plate of
pasta at lunch, meat and vegetables at dinner).
For each simulation the average glycemia, the maximal
observed glycemia and the time necessary to reach normo-
glycemia after each meal for the last simulated day are
recorded and compared among scenarios. All simulations were
performed under Matlab v7.10.0 (R2010a) [7].
III. RESULTS
Fig. 2 reports the four foodstuff types of each daily meal
for a complete run of 20 days. The top panel shows the simple
sugars time-course (administered only once daily, at breakfast),
with small spikes and fast dynamics. The following panels
report complex carbohydrate, protein and fatty food intakes
(all administered in different proportions, at each meal), show-
ing taller spikes and slower dynamics. Fig. 3 reports plasma
glucose (upper panel) and plasma insulin (bottom panel)
concentrations following the meals and the insulin injections
(central panels). As it can be seen, the equilibrium dynamics
is quickly reached for all variables with fast dynamics, while
only slow-acting insulin takes several days to reach its regime.
Fig. 4–9 report the time-course of the simulated variables over
the last simulated day, where stable regime has effectively
reached for all threes scenarios. For each of scenarios 2 and 3
the 20 days run was simulated 2000 times, varying randomly
the amounts of food intake (scenarios 2 and 3) and the food
and injection administration times (only scenario 3). For these
two scenarios 90% envelopes were reported along with the
median of the obtained empirical distributions. In scenario
2 the envelopes determined by variable food intake appear
narrow around their central trends (given reasonable standard
deviations, low and high limits set for the generation of
random realizations from truncated normal distributions), with
the envelope around plasma glucose concentrations beings
more appreciable (first panel in Fig. 7). In Fig. 8 (scenario 3),
the wide envelopes are due to peaks are reached at different
times as for variable meal times, even if the median trend
results much lower that the higher percentile above all for
the first panel (simple sugars). This is due to peaks are
reached instantaneously and decrease is very fast due to the
high elimination rate (which translates into fast dynamics).
Percentiles at each time in scenario 3 must be interpreted with
caution, since at each time the observed values derive from
curves in different phases of the respective dynamics.
IV. DISCUSSION
While conceptually simple, the set of simulations reported
may be of interest due to a combination of reasons. First
of all, care has been taken in following the fate of glucose
in plasma, as determined by a realistic representation of the
accidental variations in lifestyle of real-life subjects. Actual
therapeutic schedule of a real person has been used, populating
the model with parameters taken from statistically accurate
Fig. 2. Simulation of twenty days food intake for scenario 1
Fig. 3. Simulation of twenty days from scenario 1: glucose and insulin
concentrations (first and last graph) along with quantity of slow (second graph)
and fast (third graph) injected insulin for scenario 1
fitting procedures performed on large data sets, introducing a
realistic variation in the composition of different meals.
The simple models used have been proven in several pub-
lications being robust, reliable and giving rise in particular
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Fig. 4. Last day food intake for scenario 1
Fig. 5. Last day glucose and insulin concentrations (first and last graph) along
with quantity of slow (second graph) and fast (third graph) injected insulin
for scenario 1
Fig. 6. Last day food intake for scenario 2
Fig. 7. Last day glucose and insulin concentrations (first and last graph) along
with quantity of slow (second graph) and fast (third graph) injected insulin
for scenario 2
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Fig. 8. Last day food intake for scenario 3
Fig. 9. Last day glucose and insulin concentrations (first and last graph) along
with quantity of slow (second graph) and fast (third graph) injected insulin
for scenario 3
to coherent physiological behavior and with estimated param-
eters within acceptable ranges of variability. The performed
simulations reproduce glycemic profiles in accordance with
expectations. Consequently, the aim of providing a reliable
simulation platform for testing alternative therapeutic regimens
or other control strategies, appears essentally met.
However, interpretation of the simulations produced sug-
gests a rather interesting, unexpected phenomenon, which, if
confirmed, may be of substantial importance in both diabetes
care and in forecasting glycemic levels for control purposes.
It appears that the 90% confidence envelopes are much
wider when variability in the timing of food administration
is allowed, rather when simple variability of food amount
is present. In other words, it seems that glycemias can be
predicted (hence controlled) much better if the patients allow
themselfs some elasticity in how much food they consume,
rather than when they are irregular in their eating times.
This potentially interesting conclusion needs to be con-
firmed by a thorough investigation of the relative sizes of the
variance in food intake with respect to the variance in meal
times over populations of interest. However, if it confirmes, the
practical applications would be very concrete: in the effort to
predict future glycemia, e.g. in a control environment, precise
quantification of meal timing would be much more important
than precise quantification of calorie content.
V. CONCLUSION
A robust, simple model has been constructed, able to repli-
cate well the observed glycemic profiles in Type 1 Diabetes
Mellitus patients in common real-life conditions, combining
meals with fast and slow subcutaneous insulin administration.
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